Earnings Release • Nov 8, 2023
Earnings Release
Open in ViewerOpens in native device viewer

08 November 2023

01 _ Overview
Page 02
02 _ Key Figures 9M/2023 03 _ Outlook 2023 04 _ Appendix


01 Significant progress in profitability in Q3 with an operating EBIT margin of 16.2% (previous year: 13.8%) 05 Double-digit earnings target sustainably achieved with
EBIT margin of 14.0% (previous year: 13.7%)
02 Positive development reflects successful turnaround of subsidiary APT, implemented price adjustments and further cost optimisations 06 Stable liquidity situation despite strategic
working capital build-up - high cash position at EUR 9.6 million
03 High demand momentum in the aviation business and the life science and medical technology sectors 07
04 Broad diversification is reflected in stable revenue development

Robust order situation - incoming orders remain at a satisfactory normal level
04




§ Revenue increase of 3.8% in 9M/2023 compared to prior-year period
§ Group operating EBIT up 6.1% than the prior-year period
§ Operating EBIT margin rises to 14.0% after nine months (9M/2022: 13.7%)
§ Significant margin increase in Q3 with 16.2% operating EBIT margin (previous year: 13.8%)
| In EUR million | 9M/2023 | 9M/2022 | Change | |
|---|---|---|---|---|
| Revenue | 79.0 | 76.0 | +3.8% | |
| EBITDA | 14.7 | 14.1 | +4.6% | |
| EBIT (operating) | 11.0 | 10.4 | +6.1% | |
| Group result | 7.2 | 7.3 | -1.3% | |
| EPS (in EUR) | 0.75 | 0.76 | -1.3% |

Page 07



30,0
34,0
38,0
42,0
46,0
50,0
54,0
58,0
62,0




Positive price effects due to subsequent price adjustments with a corresponding effect on revenue and results
Stable growth in business thanks to broad industry expertise
Continuous and sustainable implementation of further measures to increase efficiency
For 2023: continued growth in revenue to EUR 103 million to EUR 110 million expected (2022: EUR 100.3 million)
Operating EBIT to increase to between EUR 11 million and EUR 14 million in 2023 (2022: EUR 11.4 million) - Stabilisation and further expansion of the yield level achieved
Recessionary trends in traditional customer industries are (over)compensated by medical technology, life-science, semiconductor technology and aviation
Solid order backlog and robust order intake

Forecast for 2023 confirmed despite economic, interest rate and geopolitical uncertainties confirmed



11

| in thousand EUR | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | 9M/2023 |
|---|---|---|---|---|---|---|
| Revenue | 77,243 | 79,969 | 71,881 | 79,068 | 100,274 | 78,967 |
| EBITDA | 9,592 | 9,656 | 7,892 | 10,670 | 16,436 | 14,729 |
| EBIT (operating) | 6,251 | 5,058 | 3,167 | 5,764 | 11,395 | 11,043 |
| Group result | 3,373 | 2,532 | 793 | 3,282 | 7,777 | 7,240 |
| EPS (in Euro) | 0.35 | 0.26 | 0.08 | 0.34 | 0.81 | 0.75 |


Page 12
Masterflex SE Mark Becks, CFO Willy-Brandt-Allee 300 45891 Gelsenkirchen
CROSS ALLIANCE communication GmbH Susan Hoffmeister Bahnhofstraße 98 82166 Graefelfing/Munich Phone
Phone.: +49 209 97077 0 Fax: +49 209 97077 33
Tel.: +49 89 125 09 03 33

[email protected] [email protected]


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.